<DOC>
	<DOCNO>NCT00238446</DOCNO>
	<brief_summary>This purpose extension study patient treat EC-MPS ass long term safety medication .</brief_summary>
	<brief_title>Efficacy Safety Enteric-coated Mycophenolate Sodium Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patients participate core study CERL080A2401 successfully complete first 12 month core study Patients complete 12month core study CERL080A2401 Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Enteric-coated mycophenolate sodium , heart transplant recipient , long term safety</keyword>
</DOC>